Coral Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.95 Cr
as on 17-12-2024
- Paid Up Capital ₹ 1.06 Cr
as on 17-12-2024
- Company Age 41 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 21.99 Cr
as on 17-12-2024
- Revenue 15.79%
(FY 2022)
- Profit -16.18%
(FY 2022)
- Ebitda 33.92%
(FY 2022)
- Net Worth 3.50%
(FY 2022)
- Total Assets -3.95%
(FY 2022)
About Coral Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.95 Cr and a paid-up capital of Rs 1.06 Cr.
The company has closed loans amounting to ₹21.99 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Binay Bhuwania, Meena Bhuwania, Pawan Agarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299DL1983PTC091164
- Company No.
091164
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 1983
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Coral Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Binay Bhuwania  | Managing Director | 27-Oct-1983 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meena Bhuwania | Director | 17-Aug-2007 | Current |
| Pawan Agarwal | Whole-Time Director | 28-Sep-2006 | Current |
| Rohit Bhuwania | Director | 01-Jul-1999 | Current |
Financial Performance of Coral Chemicals.
Coral Chemicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.79% increase. The company also saw a substantial fall in profitability, with a 16.18% decrease in profit. The company's net worth moved up by a moderate rise of 3.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Coral Chemicals?
Unlock access to Coral Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Coral Drugs Private LimitedActive 30 years 11 monthsBinay Bhuwania, Meena Bhuwania and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 22 Feb 2010 | ₹1.00 Cr | Satisfied |
Bank Of India Creation Date: 30 Dec 2006 | ₹8.09 Cr | Satisfied |
Bank Of India Creation Date: 26 Dec 2006 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Coral Chemicals?
Unlock and access historical data on people associated with Coral Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Coral Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coral Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
